Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections

被引:97
|
作者
Sprong, Tom
Roos, Dirk
Weemaes, Corry
Neeleman, Chris
Geesing, Christel L. M.
Mollnes, Tom Eirik
van Deuren, Marcel
机构
[1] Univ Nijmegen, Radboud Med Ctr, Dept Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen, Radboud Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen, Radboud Med Ctr, Dept Intens Care, NL-6500 HB Nijmegen, Netherlands
[4] Univ Nijmegen, Ctr Infect Dis, Nijmegen, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
[6] Univ Amsterdam, Acad Med Ctr, Netherlands Blood Transfus Serv, Cent Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands
[7] Bernhoven Hosp, Dept Pediat, Oss, Netherlands
[8] Univ Oslo Hosp, Rikshosp, Inst Immunol, Oslo, Norway
关键词
D O I
10.1182/blood-2005-07-2820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complement system is an essential element in our innate defense against infections with Neisseria meningitidis. We describe 2 cases of meningococcal septic shock, 1 of them fatal, in 2 children of a Turkish family. In the surviving patient, alternative pathway activation was absent and factor D plasma concentrations were undetectable. Concentrations of mannose-binding lectin (MBL), C1q, C4 and C3, factor B, properdin, factor H, and factor I were normal. Mutation analysis of the factor D gene revealed a T638 > G (Val213 > Gly) and a T640 > C (Cys214 > Arg) mutation in the genomic DNA from the patient, both in homozygous form. The consanguineous parents and an unaffected sister had these mutations in heterozygous form. In vitro incubation of factor-D-deficient plasma of the boy with serogroup B N meningitidis showed normal MBL-mediated complement activation but no formation of the alternative pathway C3-convertase C3bBbP, and severely decreased C3bc formation and terminal complement activation. The defect was restored after supplementation with factor D. In conclusion, this is the second report of a factor D gene mutation leading to factor D deficiency in a family with meningococcal disease. This deficiency abolishes alternative-pathway dependent complement activation by N meningitidis, and leads to an increased susceptibility to invasive meningococcal disease.
引用
收藏
页码:4865 / 4870
页数:6
相关论文
共 50 条
  • [1] Activation of alternative complement pathway without complement factor D
    Zhang, Yuzhou
    Keenan, Adam
    Lindorfer, Margaret A.
    Pitcher, Gabriella R.
    Taylor, Ronald P.
    Lambris, John D.
    Smith, Richard J. H.
    MOLECULAR IMMUNOLOGY, 2017, 89 : 173 - 173
  • [2] A family with complement factor D deficiency
    Biesma, DH
    Hannema, AJ
    van Velzen-Blad, H
    Mulder, L
    van Zwieten, R
    Kluijt, I
    Roos, D
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02): : 233 - 240
  • [3] Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
    Katschke, Kenneth J., Jr.
    Wu, Ping
    Ganesan, Rajkumar
    Kelley, Robert F.
    Mathieu, Mary A.
    Hass, Philip E.
    Murray, Jeremy
    Kirchhofer, Daniel
    Wiesmann, Christian
    Campagne, Menno van Lookeren
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (16) : 12886 - 12892
  • [4] Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
    Barratt, Jonathan
    Weitz, Ilene
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Complement activation in factor D-deficient mice
    Xu, YY
    Ma, MH
    Ippolito, GC
    Schroeder, HW
    Carroll, MC
    Volanakis, JE
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) : 14577 - 14582
  • [6] A New Homozygous Mutation in Complement Factor D Associated with Meningococcal Septicaemia and Absent Haemolytic Function of the Alternative Complement Pathway
    Lear, S.
    Harvey, J.
    Kumararatne, D.
    Thaventhiran, J.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S250 - S250
  • [7] A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway
    Sng, Christopher C. T.
    O'Byrne, Sorcha
    Prigozhin, Daniil M.
    Bauer, Matthias R.
    Harvey, Jennifer C.
    Ruhle, Michelle
    Challis, Ben G.
    Lear, Sara
    Roberts, Lee D.
    Workman, Sarita
    Janowitz, Tobias
    Magiera, Lukasz
    Doffinger, Rainer
    Buckland, Matthew S.
    Jodrell, Duncan J.
    Semple, Robert K.
    Wilson, Timothy J.
    Modis, Yorgo
    Thaventhiran, James E. D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (01) : 311 - 314
  • [8] MECHANISM OF ACTION OF FACTOR-D OF ALTERNATIVE COMPLEMENT PATHWAY
    LESAVRE, PH
    MULLEREBERHARD, HJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (06): : 1498 - 1509
  • [9] Complement factor B and the alternative pathway of complement activation in bovine milk
    Rainard, P
    JOURNAL OF DAIRY RESEARCH, 2002, 69 (01) : 1 - 12
  • [10] Complement factor I deficiency in a family with recurrent infections
    Leitao, MF
    Vilela, MMS
    Rutz, R
    Grumach, AS
    Condino-Neto, A
    Kirschfink, M
    IMMUNOPHARMACOLOGY, 1997, 38 (1-2): : 207 - 213